Clinical trial

Evaluating Liraglutide in Alzheimer's Disease

NCT01843075

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2014-01-01

PhasePHASE2

Study timeline

Study start (actual)2014-01-01Date precision: month

Registry last updated2019-06-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer's Diseaseunresolved

Interventions

LiraglutideDRUG · verified · RxNorm: liraglutide

Sponsors & collaborators

Imperial College Londonlead sponsor

King's College Hospital NHS Trustcollaborator

University of Oxfordcollaborator

University of Southamptoncollaborator

Avon and Wiltshire Mental Health Partnership NHS Trustcollaborator

Mapped research locations

LondonUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01843075 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.